CHEMBIO DIAGNOSTICS, INC. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018
REVENUES
Product
R&D and Grant Revenue
R&D Revenue
Government Grant Income
License and Royalty Revenue
Total rEVENUES

COSTS AND EXPENSES:
Cost of product sales
Research and development expenses
Selling, general and administrative expenses
Severance and related costs
Impairment, restructuring, severance and related costs
Acquisition costs
TOTAL OPERATING EXPENSES
TOTAL COSTS AND EXPENSES

LOSS FROM OPERATIONS
OTHER INCOME (EXPENSE):
Interest income, net
Interest (expense)/ income, net
Other income

LOSS BEFORE INCOME TAXES BENEFIT
Income tax (expense)/benefit
NET LOSS
Basic loss per share (in dollars per share)
Diluted loss per share (in dollars per share)
Weighted average number of shares outstanding, basic (in shares)
Weighted average number of shares outstanding, diluted (in shares)

Comments